======= FTSJ1 ======= == Gene Information == * **Official Symbol**: FTSJ1 * **Official Name**: FtsJ RNA 2'-O-methyltransferase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=24140|24140]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UET6|Q9UET6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FTSJ1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FTSJ1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300499|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the methyltransferase superfamily. The encoded protein localizes to the nucleolus, binds to S-adenosylmethionine, and may be involved in the processing and modification of ribosomal RNA. Mutations in this gene are associated with cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]. * **UniProt Summary**: Methylates the 2'-O-ribose of nucleotides at positions 32 and 34 of the tRNA anticodon loop of substrate tRNAs. {ECO:0000255|HAMAP-Rule:MF_03162}. |FtsJ| |tRNA nucleoside ribose methylation| |tRNA (guanosine-2-O-)-methyltransferase activity| |tRNA (cytosine-2-O-)-methyltransferase activity| |tRNA methyltransferase activity| |tRNA methylation| |cytoplasmic translation| |RNA methylation| |tRNA modification| |tRNA processing| |RNA modification| |tRNA metabolic process| |macromolecule methylation| |methylation| |translation| |ncRNA processing| |peptide biosynthetic process| |ncRNA metabolic process| |amide biosynthetic process| |peptide metabolic process| |cellular amide metabolic process| |RNA processing| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|-2.44| |[[:results:exp453|B02 10μM R08 exp453]]|-2.08| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-2.05| |[[:results:exp236|GSK2606414 1μM R05 exp236]]|-2.03| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.95| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-1.82| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.73| |[[:results:exp280|Daidzin 10μM R06 exp280]]|-1.73| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-1.73| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.94| ^Gene^Correlation^ |[[:human genes:g:gtpbp2|GTPBP2]]|0.408| |[[:human genes:r:rnaseh2b|RNASEH2B]]|0.406| Global Fraction of Cell Lines Where Essential: 0/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5643 * **Expression level (log2 read counts)**: 5.81 {{:chemogenomics:nalm6 dist.png?nolink |}}